ask="3.29"
ask_size="700"
average_daily_volume="1176190"
bid="2.81"
bid_size="19900"
book_value="2.06"
change="+0.13"
change_from_200_day_moving_average="1.17"
change_from_50_day_moving_average="0.45"
change_from_52_week_high="-4.04"
change_From_52_week_low="1.96"
change_in_percent="+4.87%"
close="2.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-138.84M"
eps_estimate_current_year="-0.71"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-1.39"
ex_dividend_date="N/A"
float_shares="38652000"
high="2.92"
high_52_weeks="6.84"
last_trade_date="3/7/2017"
last_trade_price="2.80"
last_trade_size="300"
last_trade_time="3:59pm"
low="2.60"
low_52_weeks="0.84"
market_capitalization="139.24M"
moving_average_200_day="1.63"
moving_average_50_day="2.35"
name="Infinity Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.00"
open="2.64"
pe_ratio="N/A"
peg_ratio="-0.05"
percent_change_from_200_day_moving_average="+71.79%"
percent_change_from_50_day_moving_average="+19.19%"
percent_change_from_52_week_high="-59.06%"
percent_change_from_52_week_low="+233.25%"
previous_close="2.67"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.30"
price_per_sales="4.78"
revenue="27.80M"
shares_outstanding="49729000"
short_ratio="1.83"
stock_exchange="NMS"
symbol="INFI"
volume="757256"
weeks_range_52="0.84 - 6.84"
